Sodium Bicarbonate in Cardiac Surgery Study

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

January 31, 2012

Conditions
Cardiac SurgeryCardiopulmonary Bypass
Interventions
DRUG

Sodium Bicarbonate

In all patients body weight adjusted dose of study medication will be achieved by infusion of sodium bicarbonate at a dose of 0.5 mmol/kg body weight (=bolus) diluted in 250 mL over 1 hour immediately after the induction of anesthesia, prior to the first surgical incision followed by continuous intravenous infusion of 0.2 mmol/kg/hr (=maintenance) diluted in 1000 mL 23 hours (total dose of 5 mmol/kg over 24 hours).

DRUG

Sodium Chloride

In all patients body weight adjusted dose of study medication will be achieved by infusion of sodium chloride at a dose of 0.5 mmol/kg body weight (=bolus) diluted in 250 mL over 1 hour immediately after the induction of anesthesia, prior to the first surgical incision followed by continuous intravenous infusion of 0.2 mmol/kg/hr (=maintenance) diluted in 1000 mL 23 hours (total dose of 5 mmol/kg over 24 hours).

Trial Locations (4)

3084

Austin Health, Melbourne

13353

Charité University Medicine, Berlin

T6G 2B7

University of Alberta, Edmonton

Unknown

University Clinic Dublin, School of Medicine and Medical Science, Dublin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Austin Health

OTHER_GOV

NCT00672334 - Sodium Bicarbonate in Cardiac Surgery Study | Biotech Hunter | Biotech Hunter